Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-21-000028
Filing Date
2021-03-01
Accepted
2021-03-01 18:17:31
Documents
2
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3567
2 EDGAR SUPPORTING DOCUMENT poasablich2021.txt EX-24 3648
  Complete submission text file 0001765581-21-000028.txt   8727
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address
Sablich Kim (Reporting) CIK: 0001758790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 21700218